Generally 5-HT2C activation leads to a decrease in PFC dopamine, and 5-HT2C antagonist/inverse agonists (which do have different effects on the midbrain) tend to increase dopamine cell firing
5-HT2C antagonists injected directly into the PFC on the other hand seem to have little to no effect on dopamine in PFC